Ateb names former Fred’s exec VP pharmacy execution
RALEIGH, N.C. — Following its recent move into a larger headquarters, Ateb has announced the appointment of a new VP. The company named Shannon Strickland its VP pharmacy execution. Strickland will head up Ateb’s independent sales team and report to the company’s VP sales and marketing, Debbie Sheppard.
(Click here to read Drug Store News’ feature on Ateb from our September Code Talkers Special Report)
Strickland was most recently managing director of Fred’s Specialty Pharmacy and SVP pharmacy. He began his career at Fred’s as VP pharmacy development, overseeing all managed care contracting, pharmacy marketing, vendor relations, clinical services and medication purchasing and distribution. He has previously held positions at Walmart and Sam’s club, working as director of pharmacy operations for Georgia and Alabama.
“We are excited to have a dedicated executive with years of retail and industry experience so we can continue to implement measurable solutions and provide strategic support for our pharmacy partners,” Sheppard said.
FDA gives tentative approval to Aurobindo’s Tivicay generic
SILVER SPRING, Md. — The Food and Drug Administration has granted its tentative approval to Aurobindo Pharma for its generic of Tivicay (dolutegravir or DTG), making it the first approval for a generic of the HIV treatment recommended by the World Health Organization and the Centers for Disease Control and Prevention.
“The approval of the generic version of DTG shows the commitment towards the larger cause of bringing affordable HIV drugs to millions of people,” Aurobindo managing director N. Govindarajan said. “This is a one-of-its-kind agreement between innovator and generic company where the generic version of the drug will be launched in around three years from the originator product. Further, we are also developing a fixed-dose combination of DTG.”
Because of a licensing with Tivicay maker ViiV Healthcare allowing the generic to launch in 92 licensed countries after getting regulatory approval and the Clinton Health Access Initiative, Aurobindo expects its product to launch in sub-Saharan Africa in late 2016.
“Dolutegravir is a critical new tool that will help us achieve the UNAIDS 90-90-90 goals and an AIDS-free generation,” Clinton Health Access Initiative EVP David Ripin said. “The WHO included Dolutegravir in its recommendations for first-line therapy in 2015, and we expect rapid growth in demand now that a cost-effective generic product is available. Dolutegravir, taken with other HIV treatments, has the potential to improve the lives of millions of patients.”
Impax launches generic Metadate CD
HAYWARD, Calif. — Impax Laboratories on Thursday announced the launch of its generic of Metadate CD (methylphenidate hydrochloride) extended-release capsules.
Impax’s generic will be available in 10-, 20-, 30-, 40-, 50- and 60-mg dosage strengths. The drug had U.S. sales of about $151 million for the 12 months ended July 2016, according to IMS Health data.
Loading Post Please Wait...